- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05600348
Dose-dependent Identification of Unique Biomarkers
December 12, 2023 updated by: Shirin Hooshmand, San Diego State University
Personalized Pork: Dose-dependent Identification of Unique Biomarkers
The purpose of the research is to assess the dose-dependent impacts of the consumption of fresh pork on blood-borne metabolites (markers) following the controlled feeding of pork
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Eligible participants will follow 3 randomly ordered 4-week feeding periods varying only with the consumption of 0, 3 or 6 oz of pork or a 50:50 blend of chicken and beef (6, 3 and 0 oz for respective trials to ensure similar total poultry/meat intake among trials).
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92182
- School of Exercise and Nutritional Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- generally healthy (i.e., an absence of diagnosed chronic illnesses and inborn metabolic disorders)
- Age 18-65
- all races
- both sexes
- willingness to comply with the research diet requirements
Exclusion Criteria:
- special dietary needs (e.g., vegetarianism, gluten-free, etc.)
- use of medication known to influence metabolism
- smoking
- substance use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 0 oz Pork
Participants receive 0 oz pork and 6 oz 50:50 blend of chicken and beef per day
|
Feeding of pork is controlled at 0, 3 or 6 oz per day for 4 weeks each in random order.
|
Experimental: 3 oz Pork
Participants receive 3 oz pork and 3 oz 50:50 blend of chicken and beef per day
|
Feeding of pork is controlled at 0, 3 or 6 oz per day for 4 weeks each in random order.
|
Experimental: 6 oz Pork
Participants receive 6 oz pork and 0 oz 50:50 blend of chicken and beef per day
|
Feeding of pork is controlled at 0, 3 or 6 oz per day for 4 weeks each in random order.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic biomarker discovery
Time Frame: 4 weeks
|
Biomolecules detected through metabolomic profiling that will result in discovery of a metabolic signature for pork intake
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Pressure
Time Frame: 4 weeks
|
Systolic and Diastolic
|
4 weeks
|
Body Composition
Time Frame: 4 weeks
|
Weight measured via scalre, body fat% muscle mass as measured via DEXA
|
4 weeks
|
Fasted Glucose
Time Frame: 4 weeks
|
Fasted Glucose
|
4 weeks
|
Insulin
Time Frame: 4 weeks
|
Insulin
|
4 weeks
|
HDL Cholesterol
Time Frame: 4 weeks
|
HDL Cholesterol
|
4 weeks
|
Total Cholesterol
Time Frame: 4 weeks
|
Total Cholesterol
|
4 weeks
|
LDL-Cholesterol
Time Frame: 4 weeks
|
LDL-Cholesterol
|
4 weeks
|
Triglycerides
Time Frame: 4 weeks
|
Triglycerides
|
4 weeks
|
Interleukin-6
Time Frame: 4 weeks
|
Interleukin-6
|
4 weeks
|
C-Reactive Protein
Time Frame: 4 weeks
|
C-Reactive Protein
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shirin Hooshmand, PhD, San Diego State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
October 22, 2022
First Submitted That Met QC Criteria
October 26, 2022
First Posted (Actual)
October 31, 2022
Study Record Updates
Last Update Posted (Estimated)
December 18, 2023
Last Update Submitted That Met QC Criteria
December 12, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5A949A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Pork Consumption
-
Universidad Católica San Antonio de MurciaUnknownCardiovascular Diseases | HypertensionSpain
-
University of HelsinkiCompletedCardiovascular DiseasesFinland
-
University of CopenhagenDanish Meat Research InstituteCompleted
-
University of North Carolina, Chapel HillRevivicor, IncRecruitingVomiting | Irritable Bowel Syndrome | Abdominal Pain | Diarrhea | Alpha-Gal SyndromeUnited States
-
University of Illinois at Urbana-ChampaignRecruiting
-
Purdue UniversityCompletedProtein DepositionUnited States
-
Purdue UniversityCompleted
-
The International Livestock Research Institute...Emory University; National Animal Health and Production Research Institute,... and other collaboratorsCompletedFood Safety | Food Borne DiseasesCambodia
-
University of California, DavisRockefeller UniversityCompleted